Most analysts tracking Questcor Pharmaceuticals are still rating it a buy, despite the stock diving nearly 50% on Wednesday over concerns that insurance companies were moving to limit coverage of the company’s primary revenue …
Ireland-based Mallinckrodt will buy US rival Questcor Pharmaceuticals in a roughly $US5.6 billion ($A6.05 billion) cash-and-stock deal expected to expand the firm's drive in the specialty drugs field, the companies say. The acquisition was …
SBS3y
Mallinckrodt is buying California-based Questcor Pharmaceuticals Inc. for a combination of stock and cash valued at about $5.6 billion that will help to further diversify the Irish company's business. Mallinckrodt makes a range of specialty …
It's better news for Agios Pharmaceuticals (AGIO). The stock ended up over 25% after the company reported promising results in the first clinical trial of its leukemia drug. Questcor Pharmaceutical (QCOR)was one of the top trending …
These companies are selected based on a number of requirements, including having an annual revenue between $5 million and $1 billion, they need to have traded for more than a year, and boast a stock price ... on their way up. Questcor
ANAHEIM — Mallinckrodt is buying Anaheim-based Questcor Pharmaceuticals Inc. for a combination of stock and cash valued at about $5.2 billion. Mallinckrodt makes a range of specialty pharmaceuticals. Questcor's primary product is …
Mallinckrodt is buying Anaheim's Questcor Pharmaceuticals Inc. for a combination of stock and cash valued at about $5.6 billion that will help to further diversify the Irish company's business. Mallinckrodt makes a range of specialty …
According to the complaint filed in the U.S. District Court for the Central District of California the plaintiff alleges on …
As a result of the merger, shareholders are anticipated to receive $30 in cash and .897 shares of Mallinckrodt for each …